Genomic data advances precision medicine for prostate cancer
As disease treatments continue to advance and become more personalized, researchers are increasingly relying on genomic data to accelerate the development of precision medicine for a range of conditions.
Recently, investigators have shifted their focus to prostate cancer, a condition that impacts about one in eight American men. While prostate cancer is prevalent across all patient populations, black men in the US have a higher lifetime risk of the disease – and a higher rate of mortality from the disease – than their white counterparts.
Source: Jessica Kent - Health IT Analytics